SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Receives Ethics Approval For Phase II Ebola Trial In DRC. NanoViricides, Inc. (NYSE American: NNVC) announced it has received National Ethics Committee approval in the Democratic Republic of the Congo ...
Trial met both co-primary endpoints of mean change from baseline in BCVA letter score and mean change from baseline CST with statistical ...
FDA Drug Approvals and Regulatory Updates The table below is a review of notable updates that occurred in June 2026 for investigational products in development (not an inclusive list). Click on the ...
New details on the alleged planned attack on the White House during the UFC Freedom 250 event have been revealed after eight ...
The Majorana 2 quantum chip embodies Microsoft's efforts to use a topological architecture to pursue fault-tolerant quantum ...
NRC staff recommends a construction permit for TVA's BWRX-300 SMR at Clinch River, marking a historic BWRX-300 reactor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results